U.S. market Closed. Opens in 17 hours 12 minutes

GPCR | Structure Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/AN/AN/AN/A
Cost of Revenue949.17K623.26K266.35K20.03K
Gross Profit-949.17K-623.26K-266.35K-20.03K
Operating Expenses101.74M52.56M37.70K15.91K
Selling, General & Admin31.69M16.37M8.59K3.54K
Research & Development70.04M36.19M29.11K12.36K
Other Operating ExpensesN/AN/AN/AN/A
Operating Income-102.69M-52.56M-37.70K-15.91K
Other Expenses / Income13.38M1.26M-122.00168.00
Before Tax Income-89.31M-51.30M-37.82K-15.74K
Income Tax Expenses235.79K17.00K231.00138.00
Net Income-89.54M-51.32M-38.05K-15.88K
Interest Expenses13.39M-1.53M122.16KN/A
Basic Shares Outstanding36.73M36.59M36.59M36.59M
Diluted Shares Outstanding36.73M36.59M36.59M36.59M
EBITDA-101.74M-52.56M-37.62K-15.91K
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-75.92M-52.84M84.34K-15.74K
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙